<p>(A) Mice were immunized twice with Gcf s.l., once with FI-RSV by food-pad injection, or 1×10<sup>5</sup> PFU of live RSV A2 via i.n. route, and then challenged with RSV three weeks after final immunization. Lung mononuclear cells were prepared from the lungs of the same group of mice (<i>n</i> = 6) four days after challenge and then stimulated with G(183–195) peptide in the presence of Brefeldin A. Cells were stained for CD4, CD44, and IFN-γ, and analyzed by flow cytometry. Cells gated for CD4 expression are shown in each dot plot and the percentages represent the frequency of G-specific IFN-γ-positive cells The numbers in the upper right quadrant indicate the percentage of IFN-γ+ cells among total lung CD4+ cells after subtracting the p...
<p>Mice were immunized twice with 20 µg of wtAGcf, AGcf/BCD4, BGcf/ACD4, or wtBGcf in the presence o...
<p>Mice were immunized with Ad85A i.n. (Ad85A i.n.) or primed with BCG and boosted 8 weeks later wit...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2 (FI-A2) and then s.c. vaccinated with ...
<p>Mice were immunized twice with 20 µg of wtAGcf, or wtBGcf in the presence of 2 µg of CT sublingua...
<p>Mice was immunized twice with Gcfs sublingually or FI-RSV through foot-pad route and then challen...
<p>After RSV B (KR/B/10-12) challenge, all mice (n = 4/group) were sacrificed and lung mononuclear c...
<p>Each group of mice was immunized and sacrificed as described in the materials and methods section...
<p>Antigen specific CD4 and CD8 T cells in rH4/Ad-H4 vaccinated mice were measured two weeks before ...
<p>(A) Mice were immunized and challenged as in <a href="http://www.plosone.org/article/info:doi/10....
<p>(A) BALB/c mice were immunized twice with 20 µg of recombinant Gcf or mutant GcfΔCys4 via intrana...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>Mice (n = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>Three weeks after the final immunization, mice from each group (n = 5) were sacrificed and lung c...
<p>Mice were immunized with the indicated RSV sF (0.3 μg) vaccine formulations at days 0 and 14 or w...
<p>At day 4 post RSV infection, lung homogenates were prepared and the following were measured. (A) ...
<p>Mice were immunized twice with 20 µg of wtAGcf, AGcf/BCD4, BGcf/ACD4, or wtBGcf in the presence o...
<p>Mice were immunized with Ad85A i.n. (Ad85A i.n.) or primed with BCG and boosted 8 weeks later wit...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2 (FI-A2) and then s.c. vaccinated with ...
<p>Mice were immunized twice with 20 µg of wtAGcf, or wtBGcf in the presence of 2 µg of CT sublingua...
<p>Mice was immunized twice with Gcfs sublingually or FI-RSV through foot-pad route and then challen...
<p>After RSV B (KR/B/10-12) challenge, all mice (n = 4/group) were sacrificed and lung mononuclear c...
<p>Each group of mice was immunized and sacrificed as described in the materials and methods section...
<p>Antigen specific CD4 and CD8 T cells in rH4/Ad-H4 vaccinated mice were measured two weeks before ...
<p>(A) Mice were immunized and challenged as in <a href="http://www.plosone.org/article/info:doi/10....
<p>(A) BALB/c mice were immunized twice with 20 µg of recombinant Gcf or mutant GcfΔCys4 via intrana...
<p>CB6F1 mice were vaccinated once with Ad-H4, twice with rH4 in cationic liposomes, or once with rH...
<p>Mice (n = 7 per group) were immunized at days 0 and 14 with the indicated vaccines and challenged...
<p>Three weeks after the final immunization, mice from each group (n = 5) were sacrificed and lung c...
<p>Mice were immunized with the indicated RSV sF (0.3 μg) vaccine formulations at days 0 and 14 or w...
<p>At day 4 post RSV infection, lung homogenates were prepared and the following were measured. (A) ...
<p>Mice were immunized twice with 20 µg of wtAGcf, AGcf/BCD4, BGcf/ACD4, or wtBGcf in the presence o...
<p>Mice were immunized with Ad85A i.n. (Ad85A i.n.) or primed with BCG and boosted 8 weeks later wit...
<p>Mice were i.m. vaccinated with formalin inactivated RSV A2 (FI-A2) and then s.c. vaccinated with ...